NCT03629067View on ClinicalTrials.gov

Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 13, 2018

Primary Completion Date

November 29, 2018

Study Completion Date

December 27, 2018

Conditions
Pharmacokinetics
Interventions
DRUG

Treatment T

Fixed dose Combination of Fimasartan/Amlodipine/Hydrochlorothiazide

DRUG

Treatment R

Co-administration of Fimasartan/Amlodipine and Hydrochlorothiazide

Trial Locations (1)

100-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT03629067 - Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects | Biotech Hunter | Biotech Hunter